NeoGenomics, Inc.
| Security | NEO / NeoGenomics, Inc. |
| Insider | Lawrence Martin Weiss |
This page shows the track record and history of Weiss Lawrence Martin
insider trades in NeoGenomics, Inc.. The SEC defines Insiders as officers, directors, or significant investors (greater than 10% ownership) in a company.
It is illegal for insiders to make trades in their companies based on material, non-public information ("MNPI"). This does not mean
it is illegal for them to make any
trades in their own companies. However, they must report all trades to the SEC via a Form 4.
Insider Purchases - Short Term Profit Analysis
In this section, we analyze the profitability of every unplanned, open-market insider purchase made by Lawrence Martin Weiss in NEO / NeoGenomics, Inc.. This analysis helps to understand if the insider consistently generates abnormal returns, and is worth following. This analysis is for one-year following each trade, and the results are theoretical.
The following table shows the most recent open market purchases that were not part of an automatic trading plan.
| Trade Date | Reported Shares |
Reported Price |
Adjusted Shares |
Adjusted Price |
Cost Basis | Days to Max |
Price at Max |
Max Profit ($) |
Max Return (%) |
|---|---|---|---|---|---|---|---|
| There are no known unplanned open-market trades for this insider |
Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.
Insider Sales - Short Term Loss Analysis
In this section, we analyze the short-term loss avoidance of every unplanned, open-market insider sale made by Lawrence Martin Weiss in NEO / NeoGenomics, Inc.. A consistent pattern of loss avoidance may suggest that future sale transactions may predict declines in price. This analysis is for one-year following each trade, and the results are theoretical.
The following table shows the most recent open market purchases that were not part of an automatic trading plan.
| Trade Date | Reported Shares |
Reported Price |
Adjusted Shares |
Adjusted Price |
Cost Basis | Days to Min |
Price at Min |
Max Loss Avoided ($) |
Max Loss Avoided (%) |
|---|---|---|---|---|---|---|---|---|---|
| 2020-12-14 | 20,200 | 51.0600 | 20,200 | 51.0600 | 1,031,412 | 354 | 30.49 | -415,514 | -40.29 |
Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.
Insider Transaction History
| File Date |
Trade Date |
Form | Insider | Ticker | Security Title | Code | Direct | Exercise Price |
Unit Price |
Units Changed |
Value Changed (1K) |
Remaining Options |
Remaining Shares |
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021-04-26 | 2021-04-22 | 4 | Weiss Lawrence Martin | NEO | Stock Option (Right to Buy) | D | 28.33 | -9,378 | 28,136 | |||||
| 2021-04-26 | 2021-04-22 | 4 | Weiss Lawrence Martin | NEO | Stock Option (Right to Buy) | D | 19.60 | -9,005 | 18,012 | |||||
| 2021-04-26 | 2021-04-22 | 4 | Weiss Lawrence Martin | NEO | Stock Option (Right to Buy) | D | 9.22 | -6,667 | 0 | |||||
| 2021-04-26 | 2021-04-22 | 4 | Weiss Lawrence Martin | NEO | Common Stock | D | 28.3300 | 9,378 | 266 | 130,847 | ||||
| 2021-04-26 | 2021-04-22 | 4 | Weiss Lawrence Martin | NEO | Common Stock | D | 19.6000 | 9,005 | 176 | 121,469 | ||||
| 2021-04-26 | 2021-04-22 | 4 | Weiss Lawrence Martin | NEO | Common Stock | D | 9.2200 | 6,667 | 61 | 112,464 | ||||
| 2021-03-03 | 2021-03-02 | 4 | Weiss Lawrence Martin | NEO | Stock Option (Right to Buy) | D | 53.17 | 53.1700 | 29,895 | 1,590 | 29,895 | |||
| 2021-03-03 | 2021-03-02 | 4 | Weiss Lawrence Martin | NEO | Common Stock | D | 5,276 | 105,797 | ||||||
| 2020-12-15 | 2020-12-14 | 4 | Weiss Lawrence Martin | NEO | Stock Option (Right to Buy) | D | 19.60 | -9,005 | 27,017 | |||||
| 2020-12-15 | 2020-12-14 | 4 | Weiss Lawrence Martin | NEO | Stock Option (Right to Buy) | D | 13.87 | -16,666 | 8,334 | |||||
| 2020-12-15 | 2020-12-14 | 4 | Weiss Lawrence Martin | NEO | Stock Option (Right to Buy) | D | 9.22 | -13,333 | 6,667 | |||||
| 2020-12-15 | 2020-12-14 | 4 | Weiss Lawrence Martin | NEO | Stock Option (Right to Buy) | D | 7.27 | -20,000 | 0 | |||||
| 2020-12-15 | 2020-12-14 | 4 | Weiss Lawrence Martin | NEO | Stock Option (Right to Buy) | D | 6.98 | -50,000 | 0 | |||||
| 2020-12-15 | 2020-12-14 | 4 | Weiss Lawrence Martin | NEO | Common Stock | D | 51.0600 | -20,200 | -1,031 | 100,521 | ||||
| 2020-12-15 | 2020-12-14 | 4 | Weiss Lawrence Martin | NEO | Common Stock | D | 19.6000 | 9,005 | 176 | 120,721 | ||||
| 2020-12-15 | 2020-12-14 | 4 | Weiss Lawrence Martin | NEO | Common Stock | D | 13.8700 | 16,666 | 231 | 111,716 | ||||
| 2020-12-15 | 2020-12-14 | 4 | Weiss Lawrence Martin | NEO | Common Stock | D | 9.2200 | 13,333 | 123 | 95,050 | ||||
| 2020-12-15 | 2020-12-14 | 4 | Weiss Lawrence Martin | NEO | Common Stock | D | 7.2700 | 20,000 | 145 | 81,717 | ||||
| 2020-12-15 | 2020-12-14 | 4 | Weiss Lawrence Martin | NEO | Common Stock | D | 6.9800 | 50,000 | 349 | 61,717 | ||||
| 2020-03-03 | 2020-03-02 | 4 | Weiss Lawrence Martin | NEO | Common Stock | D | 28.33 | 28.3300 | 37,514 | 1,063 | 37,514 | |||
| 2020-03-03 | 2020-03-02 | 4 | Weiss Lawrence Martin | NEO | Common Stock | D | 5,824 | 11,717 | ||||||
| 2019-03-05 | 2019-03-01 | 4 | Weiss Lawrence Martin | NEO | Stock Option (Right to Buy) | D | 19.60 | 19.6000 | 36,022 | 706 | 36,022 | |||
| 2019-03-05 | 2019-03-01 | 4 | Weiss Lawrence Martin | NEO | Common Stock | D | 5,893 | 5,893 | ||||||
| 2018-12-14 | 2018-12-12 | 4 | Weiss Lawrence Martin | NEO | Stock Option (Right to Buy) | D | 13.87 | 13.8700 | 25,000 | 347 | 25,000 |
P
Åbent marked eller privat køb af ikke-afledte eller afledte værdipapirer
S
Åbent marked eller privat salg af ikke-afledte eller afledte værdipapirer
A
Tildeling, tildeling eller anden erhvervelse af værdipapirer fra virksomheden (såsom en option)
C
Konvertering af derivat
D
Salg eller overførsel af værdipapirer tilbage til virksomheden
F
Betaling af udnyttelseskurs eller skatteforpligtelse ved brug af en del af værdipapirer modtaget fra selskabet
G
Gave af værdipapirer af eller til insideren
K
Aktieswaps og lignende sikringstransaktioner
M
Udnyttelse eller konvertering af afledt værdipapir modtaget fra virksomheden (såsom en option)
V
En transaktion rapporteret frivilligt på formular 4
J
Andet (ledsaget af en fodnote, der beskriver transaktionen)
